MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, ...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 5, 2025